These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 27034167)

  • 1. REST reduction is essential for hypoxia-induced neuroendocrine differentiation of prostate cancer cells by activating autophagy signaling.
    Lin TP; Chang YT; Lee SY; Campbell M; Wang TC; Shen SH; Chung HJ; Chang YH; Chiu AW; Pan CC; Lin CH; Chu CY; Kung HJ; Cheng CY; Chang PC
    Oncotarget; 2016 May; 7(18):26137-51. PubMed ID: 27034167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autophagy pathway is required for IL-6 induced neuroendocrine differentiation and chemoresistance of prostate cancer LNCaP cells.
    Chang PC; Wang TY; Chang YT; Chu CY; Lee CL; Hsu HW; Zhou TA; Wu Z; Kim RH; Desai SJ; Liu S; Kung HJ
    PLoS One; 2014; 9(2):e88556. PubMed ID: 24551118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MAOA-a novel decision maker of apoptosis and autophagy in hormone refractory neuroendocrine prostate cancer cells.
    Lin YC; Chang YT; Campbell M; Lin TP; Pan CC; Lee HC; Shih JC; Chang PC
    Sci Rep; 2017 Apr; 7():46338. PubMed ID: 28402333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 induces neuroendocrine differentiation (NED) through suppression of RE-1 silencing transcription factor (REST).
    Zhu Y; Liu C; Cui Y; Nadiminty N; Lou W; Gao AC
    Prostate; 2014 Aug; 74(11):1086-94. PubMed ID: 24819501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AMPK/SIRT1 signaling through p38MAPK mediates Interleukin-6 induced neuroendocrine differentiation of LNCaP prostate cancer cells.
    Natani S; Dhople VM; Parveen A; Sruthi KK; Khilar P; Bhukya S; Ummanni R
    Biochim Biophys Acta Mol Cell Res; 2021 Sep; 1868(10):119085. PubMed ID: 34171447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of RE-1 silencing transcription factor (REST) in advanced prostate cancer by hypoxia-induced miR-106b~25.
    Liang H; Studach L; Hullinger RL; Xie J; Andrisani OM
    Exp Cell Res; 2014 Jan; 320(2):188-99. PubMed ID: 24135225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HOTAIR is a REST-regulated lncRNA that promotes neuroendocrine differentiation in castration resistant prostate cancer.
    Chang YT; Lin TP; Tang JT; Campbell M; Luo YL; Lu SY; Yang CP; Cheng TY; Chang CH; Liu TT; Lin CH; Kung HJ; Pan CC; Chang PC
    Cancer Lett; 2018 Oct; 433():43-52. PubMed ID: 29944905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt-11 promotes neuroendocrine-like differentiation, survival and migration of prostate cancer cells.
    Uysal-Onganer P; Kawano Y; Caro M; Walker MM; Diez S; Darrington RS; Waxman J; Kypta RM
    Mol Cancer; 2010 Mar; 9():55. PubMed ID: 20219091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of macrophage migration inhibitory factor by neuroendocrine-differentiated LNCaP cells sustains the proliferation and survival of prostate cancer cells.
    Tawadros T; Alonso F; Jichlinski P; Clarke N; Calandra T; Haefliger JA; Roger T
    Endocr Relat Cancer; 2013 Feb; 20(1):137-49. PubMed ID: 23207293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6: a bone marrow stromal cell paracrine signal that induces neuroendocrine differentiation and modulates autophagy in bone metastatic PCa cells.
    Delk NA; Farach-Carson MC
    Autophagy; 2012 Apr; 8(4):650-63. PubMed ID: 22441019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of neuroendocrine differentiation by AKT/hnRNPK/AR/β-catenin signaling in prostate cancer cells.
    Ciarlo M; Benelli R; Barbieri O; Minghelli S; Barboro P; Balbi C; Ferrari N
    Int J Cancer; 2012 Aug; 131(3):582-90. PubMed ID: 22015967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secretogranin II is overexpressed in advanced prostate cancer and promotes the neuroendocrine differentiation of prostate cancer cells.
    Courel M; El Yamani FZ; Alexandre D; El Fatemi H; Delestre C; Montero-Hadjadje M; Tazi F; Amarti A; Magoul R; Chartrel N; Anouar Y
    Eur J Cancer; 2014 Nov; 50(17):3039-49. PubMed ID: 25307750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The retinoblastoma protein regulates hypoxia-inducible genetic programs, tumor cell invasiveness and neuroendocrine differentiation in prostate cancer cells.
    Labrecque MP; Takhar MK; Nason R; Santacruz S; Tam KJ; Massah S; Haegert A; Bell RH; Altamirano-Dimas M; Collins CC; Lee FJ; Prefontaine GG; Cox ME; Beischlag TV
    Oncotarget; 2016 Apr; 7(17):24284-302. PubMed ID: 27015368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-Regulated Expression of LAMP2 and Autophagy Activity during Neuroendocrine Differentiation of Prostate Cancer LNCaP Cells.
    Morell C; Bort A; Vara-Ciruelos D; Ramos-Torres Á; Altamirano-Dimas M; Díaz-Laviada I; Rodríguez-Henche N
    PLoS One; 2016; 11(9):e0162977. PubMed ID: 27627761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LNCaP prostate cancer cells with autocrine interleukin-6 expression are resistant to IL-6-induced neuroendocrine differentiation due to increased expression of suppressors of cytokine signaling.
    Ge D; Gao AC; Zhang Q; Liu S; Xue Y; You Z
    Prostate; 2012 Sep; 72(12):1306-16. PubMed ID: 22213096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Castration-Induced Downregulation of SPARC in Stromal Cells Drives Neuroendocrine Differentiation of Prostate Cancer.
    Enriquez C; Cancila V; Ferri R; Sulsenti R; Fischetti I; Milani M; Ostano P; Gregnanin I; Mello-Grand M; Berrino E; Bregni M; Renne G; Tripodo C; Colombo MP; Jachetti E
    Cancer Res; 2021 Aug; 81(16):4257-4274. PubMed ID: 34185677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel GRK3-HDAC2 regulatory pathway is a key direct link between neuroendocrine differentiation and angiogenesis in prostate cancer progression.
    Naderinezhad S; Zhang G; Wang Z; Zheng D; Hulsurkar M; Bakhoum M; Su N; Yang H; Shen T; Li W
    Cancer Lett; 2023 Sep; 571():216333. PubMed ID: 37543278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Notch signaling modulates hypoxia-induced neuroendocrine differentiation of human prostate cancer cells.
    Danza G; Di Serio C; Rosati F; Lonetto G; Sturli N; Kacer D; Pennella A; Ventimiglia G; Barucci R; Piscazzi A; Prudovsky I; Landriscina M; Marchionni N; Tarantini F
    Mol Cancer Res; 2012 Feb; 10(2):230-8. PubMed ID: 22172337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroendocrine differentiation in hormone refractory prostate cancer following androgen deprivation therapy.
    Hirano D; Okada Y; Minei S; Takimoto Y; Nemoto N
    Eur Urol; 2004 May; 45(5):586-92; discussion 592. PubMed ID: 15082200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SNAI2/Slug gene is silenced in prostate cancer and regulates neuroendocrine differentiation, metastasis-suppressor and pluripotency gene expression.
    Esposito S; Russo MV; Airoldi I; Tupone MG; Sorrentino C; Barbarito G; Di Meo S; Di Carlo E
    Oncotarget; 2015 Jul; 6(19):17121-34. PubMed ID: 25686823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.